According to warnings posted yesterday by the FDA, Fentora has been linked to several deaths caused by fentanyl overdose. Fentora is a newer medication, similar to the Actiq lollipop, which is only approved for use in cancer patients who have breakthrough pain not managed by other… Read More
Concerned by reports of fentanyl patch overdoses and deaths, the Institute of Safe Medicine Practices issued recommendations to reduce the dangers of fentanyl patch problems. Misinformed and careless physicians continue to prescribe the pain patch inappropriately, with doses that are too large or in combination with… Read More
According to an article in the Los Angeles Times, the degree of danger associated with the Duragesic fentanyl skin patch is still not fully appreciated by healthcare providers and deaths continue to occur at an alarming rate as a result of sudden fentanyl overdose for unsuspecting… Read More
Last month a federal jury in Florida awarded $5.5 million to the family of a 28 year old man who was found dead of fentanyl overdose after putting on the Duragesic Patch. Late last week it was reported by Bloomberg that the family and Johnson &… Read More
The makers of the Actiq lollipop pain medication are one of five pharmaceutical companies who received a letter from U.S. Congress Rep. Henry A. Waxman earlier this month, as part of his investigation into inappropriate marketing and incomplete research regarding drugs and medical devices. In recent… Read More
The powerful painkilling lollipop, Actiq, is widely overused, which increases the risk of abuse, addiction and serious side effects. A recent study confirmed that over 90% of prescriptions for Actiq are off-label, or for uses which are not approved by the FDA. As a result, thousands… Read More
The Actiq lollipop pain killer has been linked to serious and potentially fatal injuries. Saiontz and Kirk is reviewing potential lawsuits for users nationwide. Actiq is a powerful narcotic painkiller which has been approved by the FDA for treatment severe pain suffered by cancer patients which… Read More
